IL-6 Levels Predict Distant Breast Cancer Recurrence IL-6 Levels Predict Distant Breast Cancer Recurrence

Interleukin 6 may be a biomarker for distant recurrence of breast cancer among patients treated for stage II-III HER2-negative disease, investigators have found. The evidence was presented at ASCO 2021.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news